Simple Molecule Shows Remarkable Alzheimer’s Reversal in Rats
Researchers said the copper-delivering compound cut toxic amyloid-beta by 42% and improved spatial learning by nearly 44% in mice.
10 Articles
10 Articles
Copper Drug Shows Promise Against Alzheimer’s by Clearing Toxic Brain Proteins
Beta-Amyloid Plaques and Tau in the Alzheimer’s affected brain. Credit: NIH Image Gallery / Public Domain Researchers at Monash University have identified a promising Copper drug that may help treat Alzheimer’s disease by restoring the brain’s ability to clear harmful proteins. The study, published in ACS Chemical Neuroscience, found that the compound Cu(ATSM) repaired a key waste-removal system in the brain, reduced toxic protein buildup, and i…
Simple molecule shows remarkable Alzheimer’s reversal in rats
Scientists have developed a new molecule that breaks down beta-amyloid plaques by binding to excess copper in the brain. The treatment restored memory and reduced inflammation in rats, while also proving non-toxic and able to cross the blood–brain barrier. Because it’s far simpler and potentially cheaper than existing drugs, researchers are now pursuing partnerships to begin human trials.
Lab trials prove copper therapy enhances cognitive function and spatial learning
Monash University researchers have found in laboratory experiments that a drug which delivers copper to the brain significantly reduces toxic Alzheimer's proteins and improves long-term spatial memory.
New Copper Drug Could Clean Alzheimer’s Waste and Improving Memory
Alzheimer’s disease is the most common cause of dementia and one of the biggest health challenges facing the world today. It gradually damages memory, thinking abilities, and the capacity to perform everyday tasks. In the early stages, people may forget recent conversations or misplace objects more often. As the disease progresses, many struggle to recognize […] The post New Copper Drug Could Clean Alzheimer’s Waste and Improving Memory appeared…
Researchers have identified a new mechanism linked to Alzheimer's and designed a compound that slows the disease in mice. The signal is encouraging, but very preliminary.
Breakthrough Copper-Based Drug Eradicates Alzheimer's Plaques and Enhances Memory in Mice
Copper diacetylbis(4-methyl-3-thiosemicarbazone), commonly known as Cu (ATSM), has demonstrated significant potential in rejuvenating vital waste clearance mechanisms in the brain, reducing harmful amyloid beta accumulation, and enhancing spatial memory in a laboratory model of Alzheimer’s disease. This study was conducted by a dedicated research team at Monash University. The study leveraged the APP/PS1 mouse model [...] The post Breakthrough C…

Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




